Overview

The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study

Status:
Terminated
Trial end date:
2016-08-30
Target enrollment:
Participant gender:
Summary
The BRAVO study seeks to determine if dietary supplementation with omega-3 highly unsaturated fatty acids (omega-3 HUFAs) reduces the risk for serious suicidal behaviors, suicidal thinking, negative emotions, and symptoms associated with suicide risk, in a Veteran and non-Veteran population that is at risk for suicidal behaviors. This study seeks to evaluate the efficacy of omega-3 HUFAs among a representative population of US Veterans and non-Veterans already receiving appropriate medical care so that if successful, these results can be readily applied to broader populations in the US.
Phase:
Phase 1
Details
Lead Sponsor:
Medical University of South Carolina
Collaborators:
U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command